BUZZ-Minerva Neurosciences 公司获得高达 2 亿美元的私募融资，股价飙升

路透中文

Oct 21, 2025

BUZZ-<a href="https://laohu8.com/S/NERV">Minerva Neurosciences</a> 公司获得高达 2 亿美元的私募融资，股价飙升

10月21日 - ** 药物开发商Minerva NeurosciencesNERV.O股价盘前上涨132.3%至6.03美元

** 公司表示将通过私募获得高达2亿美元的总收益，用于资助后期试验和向美国FDA重新提交其精神分裂症实验药物roluperidone。

** 此次融资包括 8000 万美元的预付款，以及与 A 期认股权证的全部行使挂钩的最多 8000 万美元的额外款项。

** Minerva 公司还将扩大董事会，增加多达三名具有精神分裂症临床试验经验的董事，由投资者指定以支持临床运营。

** 此次融资由 Vivo Capital 领投，Janus Henderson Investors、Federated Hermes Kaufmann Funds、Farallon Capital 等机构参投

** 截至上一交易日收盘，股价累计上涨 19.73

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2577820588"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2577820588\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2577820588?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-10-21 20:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577820588","market":"us","top_or_hot":-1,"title":"BUZZ-Minerva Neurosciences 公司获得高达 2 亿美元的私募融资，股价飙升","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/NERV\">Minerva Neurosciences</a> 公司获得高达 2 亿美元的私募融资，股价飙升</title></head><body><p><span>10月21日</span><span> - </span>** 药物开发商Minerva Neurosciences<span>NERV.O</span>股价盘前上涨132.3%至6.03美元 </p><p>** 公司表示将通过私募获得高达2亿美元的总收益，用于资助后期试验和向美国FDA重新提交其精神分裂症实验药物roluperidone。</p><p>** 此次融资包括 8000 万美元的预付款，以及与 A 期认股权证的全部行使挂钩的最多 8000 万美元的额外款项。</p><p>** Minerva 公司还将扩大董事会，增加多达三名具有精神分裂症临床试验经验的董事，由投资者指定以支持临床运营。</p><p>** 此次融资由 Vivo Capital 领投，<a href=\"https://laohu8.com/S/JHG\">Janus Henderson</a> Investors、<a href=\"https://laohu8.com/S/FHI\">Federated Hermes</a> Kaufmann Funds、Farallon Capital 等机构参投</p><p>** 截至上一交易日收盘，股价累计上涨 19.73</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Minerva Neurosciences 公司获得高达 2 亿美元的私募融资，股价飙升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Minerva Neurosciences 公司获得高达 2 亿美元的私募融资，股价飙升\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-10-21 20:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/NERV\">Minerva Neurosciences</a> 公司获得高达 2 亿美元的私募融资，股价飙升</title></head><body><p><span>10月21日</span><span> - </span>** 药物开发商Minerva Neurosciences<span>NERV.O</span>股价盘前上涨132.3%至6.03美元 </p><p>** 公司表示将通过私募获得高达2亿美元的总收益，用于资助后期试验和向美国FDA重新提交其精神分裂症实验药物roluperidone。</p><p>** 此次融资包括 8000 万美元的预付款，以及与 A 期认股权证的全部行使挂钩的最多 8000 万美元的额外款项。</p><p>** Minerva 公司还将扩大董事会，增加多达三名具有精神分裂症临床试验经验的董事，由投资者指定以支持临床运营。</p><p>** 此次融资由 Vivo Capital 领投，<a href=\"https://laohu8.com/S/JHG\">Janus Henderson</a> Investors、<a href=\"https://laohu8.com/S/FHI\">Federated Hermes</a> Kaufmann Funds、Farallon Capital 等机构参投</p><p>** 截至上一交易日收盘，股价累计上涨 19.73</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4135","symbol_name":"资产管理与托管银行","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nL4S3W20V8:1","article_id":"2577820588","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577820588","pubTimestamp":1761048775,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"** Minerva 公司还将扩大董事会，增加多达三名具有精神分裂症临床试验经验的董事，由投资者指定以支持临床运营。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4135":"资产管理与托管银行","LU0054578231.USD":"BGF SYSTEMATIC SUSTAINABLE GLOBAL SMALLCAP \"A2\" (USD) ACC","BK4139":"生物科技","JHG":"骏利亨德森集团","NERV":"Minerva Neurosciences"},"translate_title":"BUZZ-Minerva Neurosciences Shares Surge as Inc. Raises Up to $200 Million in Private Placement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NERV":0.9,"JHG":0.9},"content_text":"BUZZ-Minerva Neurosciences 公司获得高达 2 亿美元的私募融资，股价飙升10月21日 - ** 药物开发商Minerva NeurosciencesNERV.O股价盘前上涨132.3%至6.03美元 ** 公司表示将通过私募获得高达2亿美元的总收益，用于资助后期试验和向美国FDA重新提交其精神分裂症实验药物roluperidone。** 此次融资包括 8000 万美元的预付款，以及与 A 期认股权证的全部行使挂钩的最多 8000 万美元的额外款项。** Minerva 公司还将扩大董事会，增加多达三名具有精神分裂症临床试验经验的董事，由投资者指定以支持临床运营。** 此次融资由 Vivo Capital 领投，Janus Henderson Investors、Federated Hermes Kaufmann Funds、Farallon Capital 等机构参投** 截至上一交易日收盘，股价累计上涨 19.73(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}